MS751 Cells
USUSD$550.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
一般資訊
| 說明 | MS751 is a tumorigenic human cervical carcinoma cell line isolated from the uterus of a female patient with epidermoid carcinoma. The cells were originally obtained from a metastatic lymph node, and they form poorly differentiated epidermoid carcinoma (grade III) when xenografted into nude mice. The tumorigenic and metastatic nature of MS751 cells makes them a valuable model for studying the processes involved in cervical cancer metastasis and tumor progression. These cells are particularly useful for investigating epithelial-to-mesenchymal transition (EMT), invasion, and metastasis, especially in relation to poorly differentiated carcinoma. One of the key molecular features of MS751 is the presence of human papillomavirus (HPV) sequences. Originally reported to contain HPV-18, more recent studies have demonstrated that MS751 cells contain partial sequences of HPV-45, particularly from the E6/E7 region, which are expressed as poly(A)+ RNA. The E6 and E7 oncoproteins are well-known for their roles in disrupting the tumor suppressor functions of p53 and Rb, respectively, which promote uncontrolled cell division and contribute to oncogenesis. The presence of these viral sequences makes MS751 highly relevant for studies on HPV-associated cervical cancers, and specifically for investigating how HPV-45 contributes to the malignancy of cervical cells. MS751 cells exhibit epithelial morphology, which is characteristic of many cervical cancer cell lines. They are widely used for research into the molecular mechanisms underlying HPV-mediated carcinogenesis, as well as for drug discovery and therapeutic screening. Given their metastatic origin and the presence of HPV sequences, MS751 provides an essential model for studying the progression of cervical cancer and testing therapeutic strategies aimed at targeting both viral and tumor-related pathways. |
|---|---|
| 生物體 | Human |
| 組織 | Cervix |
| 疾病 | Human papillomavirus-related cervical squamous cell carcinoma |
| 轉移部位 | Lymph node |
| 同義詞 | MS-751, MS 751 |
特徵
| 年齡 | 47 years |
|---|---|
| 性別 | European |
| 形態學 | Epithelial |
| 生長特性 | Adherent |
監管數據
| 引用 | MS751 (Cytion catalog number 305115) |
|---|---|
| 生物安全等級 | 1 |
| NCBI_TaxID | 9606 |
| Cellosaurus 編號 | CVCL_4996 |
生物分子資料
| 抗原表達 | Blood Type AB, Rh+ |
|---|---|
| 致瘤性 | Yes, in nude mice, forms poorly differentiated epidermoid carcinoma (gradeⅢ). |
| 病毒 | HPV18, HPV45 |
處理方式
| 培養基 | EMEM (MEM Eagle), w: 2 mM L-Glutamine, w: 2.2 g/L NaHCO3, w: EBSS (Cytion article number 820100a) |
|---|---|
| 營養補充品 | Supplement the medium with 10% FBS, 1% NEAA and 1.0 mM Sodium pyruvate |
| 解離試劑 | Accutase |
| 傳代培養 | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| 流體更新 | 2 to 3 times per week |
| 冷凍培養基 | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| 細胞解凍與培養 |
|
| 培養環境 | 37°C, 5% CO2, humidified atmosphere. |
| 運送條款 | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| 儲存條件 | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
品質控制與分子分析
| 不孕症 | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
分析證明書 (CoA)
| 批次編號 | 證書類型 | 日期 | 型號 |
|---|---|---|---|
| 305115-260525 | 分析證明書 | 21. Jul. 2025 | 305115 |
| 305115-270323 | 分析證明書 | 21. Jul. 2025 | 305115 |